| Product Code: ETC7549480 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India oncology-cancer drugs market import shipment demonstrated a steady growth trend with a CAGR of 3.0 from 2020 to 2024. Notably, there was a significant acceleration in growth between 2023 and 2024, with a growth rate of 26.5%, indicating a strong upward momentum in market expansion.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Oncology-Cancer Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Oncology-Cancer Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Oncology-Cancer Drugs Market - Industry Life Cycle |
3.4 India Oncology-Cancer Drugs Market - Porter's Five Forces |
3.5 India Oncology-Cancer Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India Oncology-Cancer Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 India Oncology-Cancer Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in India |
4.2.2 Growing awareness about cancer treatment options |
4.2.3 Technological advancements in oncology drugs research and development |
4.3 Market Restraints |
4.3.1 High cost associated with oncology-cancer drugs |
4.3.2 Stringent regulatory requirements for drug approval in India |
5 India Oncology-Cancer Drugs Market Trends |
6 India Oncology-Cancer Drugs Market, By Types |
6.1 India Oncology-Cancer Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Oncology-Cancer Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 India Oncology-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.4 India Oncology-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.1.5 India Oncology-Cancer Drugs Market Revenues & Volume, By Immunotherapy (Biologic Therapy), 2021- 2031F |
6.1.6 India Oncology-Cancer Drugs Market Revenues & Volume, By Hormonal Therapy, 2021- 2031F |
6.2 India Oncology-Cancer Drugs Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 India Oncology-Cancer Drugs Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.3 India Oncology-Cancer Drugs Market Revenues & Volume, By Stomach Cancer, 2021- 2031F |
6.2.4 India Oncology-Cancer Drugs Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.5 India Oncology-Cancer Drugs Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.6 India Oncology-Cancer Drugs Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.7 India Oncology-Cancer Drugs Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.2.8 India Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F |
6.2.9 India Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F |
7 India Oncology-Cancer Drugs Market Import-Export Trade Statistics |
7.1 India Oncology-Cancer Drugs Market Export to Major Countries |
7.2 India Oncology-Cancer Drugs Market Imports from Major Countries |
8 India Oncology-Cancer Drugs Market Key Performance Indicators |
8.1 Number of clinical trials conducted for oncology-cancer drugs in India |
8.2 Adoption rate of innovative cancer treatment therapies in the market |
8.3 Investment in research and development for oncology drugs in India |
9 India Oncology-Cancer Drugs Market - Opportunity Assessment |
9.1 India Oncology-Cancer Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India Oncology-Cancer Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 India Oncology-Cancer Drugs Market - Competitive Landscape |
10.1 India Oncology-Cancer Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Oncology-Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here